Sentences with phrase «cell therapy products»
Cell therapy product attributes rely heavily on the associated manufacturing processes.
bioprocessintl.com
Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
The first approved cell therapy product in Russia brought about $ 0.5 M USD in revenue last year (personal communication with CEO).
Case Studies in Multi-Parameter Flow Cytometric Characterization of TCR, TIL, and CAR - T Cell Therapy Products Sadik Kassim, PhD, Mustang Bio, United States
SAN DIEGO, July 21, 2016 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced that the California Institute for Regenerative Medicine (CIRM) approved a grant of $ 3.9 million to support pre-clinical development of ViaCyte's PEC - Direct cell therapy product candidate which is being developed for a subset of type 1 diabetes patients.
In this overview, authors from AllCells provide deeper insight into supply - chain considerations for procuring and qualifying donated tissue as a starting material for generating clinical cell therapy products.
Pluristem Therapeutics, Inc. engages in the development of standardized cell therapy products for the treatment of life threatening diseases.
Work in administration and manufacturing or processing of cell therapy products such as TIL, CAR - T cells, and stem cell or blood product transplants.
The rational is to use hPSCs as potent sources of cells to produce cell therapy product (CTP) for HD patient.
It offers to the commercialization of unrelated donor - patient (allogeneic) cell therapy products for the treatment of several severe degenerative, ischemic and autoimmune disorders.
HSCI also has a cell therapy product on the market.
Product characterization is critical, but cell therapy products are living organisms...
Cell Trials Data is devoted to compilations of data about cell therapy trials and cell therapy products.
Because of intrinsic fragility, cell therapy products can be highly sensitive to variations in manufacturing procedures.
First academic GLP center for performing biodistribution, toxicology / tumorigenicity and validation studies on gene and cell therapy products.
Axicabtagene ciloleucel, also called axi - cel, is an autologous gene - and - cell therapy product.